Selected article for: "average number and patient average number"

Author: Grimaldi, Gianluca; Ancona, Domenica; Tricarico, Domenico; Stella, Paolo; Procacci, Cataldo; Germinario, Antonio; Bavaro, Vito; Montanaro, Vito; Delle Donne, Alessandro
Title: Analysis of the Introduction in Clinical Practice of New Oral Anticoagulants in Local Health Agency BT: Translation of the Clinical Trial Data to a Local Health Care Area
  • Cord-id: equqk4nr
  • Document date: 2021_2_11
  • ID: equqk4nr
    Snippet: The commercial release of the New Oral Anticoagulants (NOACs) has been the most significant change in anticoagulant therapy in recent years. The work aimed to evaluate the economic and health impact for the Local Health Agency Barletta-Andria-Trani (BT). Through the Regional Information System data about naïve patients on NOAC treatment and patients on anti-vitamin-k (VKA), treatments were extrapolated. We assessed therapeutic continuity, pharmaceutical expenditure, hospitalizations, and deaths
    Document: The commercial release of the New Oral Anticoagulants (NOACs) has been the most significant change in anticoagulant therapy in recent years. The work aimed to evaluate the economic and health impact for the Local Health Agency Barletta-Andria-Trani (BT). Through the Regional Information System data about naïve patients on NOAC treatment and patients on anti-vitamin-k (VKA), treatments were extrapolated. We assessed therapeutic continuity, pharmaceutical expenditure, hospitalizations, and deaths in 2017 and 2018. Therapeutic continuity was similar in the two groups. The number and the average cost of hospitalizations for a patient treated with VKAs were almost constant, while those of patients treated with NOACs decreased. The treatment of adult-aged naïve patients with NOACs, compared to VKAs therapy, involves an increase in expenditure of about 100€ for a patient, but the reduced hospitalizations could generate, in the long term, saving for the Health System. Clinical data, according to the Real-World Data, confirmed the safety and effectiveness of these drugs. However, attention to the special population is necessary to improve the safety and effectiveness of NOACs. Innovative formulations for pediatric patients are being developed. The challenge for Health Systems is the appropriate use of available resources through health interventions with transversal competences.

    Search related documents:
    Co phrase search for related documents
    • access device and local health: 1
    • access device and long term therapy: 1
    • active cancer and acute treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • active cancer and local health: 1
    • active cancer and long term therapy: 1, 2
    • active cancer and long term treatment: 1, 2, 3
    • active cancer and low incidence: 1, 2
    • active cancer and low interaction: 1